Categories AlphaGraphs, Earnings, Health Care
Infographic: Key financials of Biogen (BIIB) Q2 2020 earnings report
Biogen (NASDAQ: BIIB) reported a 12% increase in adjusted EPS and 2% growth in revenue for the second quarter of 2020. Adjusted EPS of $10.26 and revenue of $3.68 billion in the quarter were better than analysts’ estimates. Shares of Biogen rose about 3% in the pre-market trading session.
While Biogen lifted its EPS guidance for fiscal 2020, it lowered the revenue expectations.
The company lifted FY20 GAAP EPS outlook to a range of $32.00 and $34.00 from the prior guidance range of $29.50 to $31.50. Non-GAAP EPS is now expected to be between $34.00 and $36.00 versus a prior range of $31.50 to $33.50.
Revenue outlook for FY20 is cut down to a range of $13.8 billion to $14.2 billion from the prior expected range of $14.0 billion to $14.3 billion.
Most Popular
CAG Earnings: Conagra Brands Q4 adj. profit drops, misses estimates
Conagra Brands, Inc. (NYSE: CAG), a leading provider of consumer packaged goods, reported lower sales and adjusted earnings for the fourth quarter of 2025. Results missed analysts' estimates. Net sales
Delta Air Lines (DAL) Q2 2025 Earnings: Key financials and quarterly highlights
Delta Air Lines (NYSE: DAL) reported its second quarter 2025 earnings results today. Operating revenue remained flat versus the year-ago quarter at $16.64 billion. GAAP net income increased 63% year-over-year
Bank earnings preview: These banking leaders will report Q2 2025 results next week, what to expect
The earnings season is set to kick off next week with quarterly reports from a number of leading banks. JPMorgan Chase & Co. (NYSE: JPM), Citigroup (NYSE: C) and Wells
